New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs

Cardiology Journal

Volumn 16, Issue 4, 2009, Pages 375-378

  Lobodzinski, S Sueve ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULATION; ARTICLE; BRAIN EMBOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART ASSIST DEVICE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; RISK FACTOR; THROMBOGENESIS; THROMBUS; TRANSIENT ISCHEMIC ATTACK;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; STROKE;

EID: 70349508847     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
2. Mant J, Hobbs FDR, Fletcher K et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet, 2007; 370: 493-503.
3. Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician, 1999; 60: 764-766.
4. Motei A, Holmes DR, Packer DL et al. Initial experience with a left atrial appendage filter device for stroke prevention in atrial fibrillation. Poster Presentation at American College of Cardiology, 2005.
5. Bayard YL, Ostermayer SH, Sievert H. Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev Cardiovasc Therapy, 2005; 3: 1003-1008.
6. Sick PB, Schuler G, Hauptmann KE et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation J Am Coll Cardiol, 2007; 49: 1490-1495.
7. Healey JS, Crystal E, Lamy A et al. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J, 2005; 150: 288-293.
8. Packer D, Krishnaswamy C, Peterson L, Monahan K, Holmes D. Utility of intracardiac ultrasound for guiding deployment of a left atrial appendage occlusion devices for LAA thrombus prevention. Featured Poster Presentation at Heart Rhythm Society, 2005.
9. Daoud E, Holmes D, Mooney M, Packer D, Yakubov S, Turi Z. Early US experience with left atrial appendage isolation. Poster Presentation at Heart Rhythm Society, 2005.
10. Jeffrey S. ACC 2009: PROTECT-AF: Device closure of LAA may provide alternative to warfarin to prevent stroke in AF. Medscape Medical News, March, 2009.
11. Fountain RB, Holmes DR, Chandrasekaran K. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial. Am Heart J, 2006; 151: 956-961.
12. Holmes D. Randomized Prospective Trial of Percutaneous Left Atrial Appendage Closure versus Warfarin for Stroke Prevention in Atrial Fibrillation (PROTECT AF). Proceedings of the 58th Scientific Sessions, Orlando, March, 2009.
13. Snapinn SM. Noninferiority trials. Curr Control Trials Cardiovasc Med, 2000; 1: 19-21.